Erratum. CT, Positron Emission Tomography, and MRI in Staging Lung Cancer (DOI:10.1016/j.ccm.2007.11.004);CT, Positron Emission Tomography, and MRI in Staging Lung Cancer

Clinics in Chest Medicine

Volumn 29, Issue 1, 2008, Pages 39-57

  Erasmus, Jeremy J ^a   Sabloff, Bradley S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINOSCOPY; METASTASIS POTENTIAL; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; UNITED STATES;

EID: 38949207235     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.03.001     Document Type: Erratum

References (90)

1. American Cancer Society on line. Available at: http//www.acs.org. August 2007.
2. Travis W.D., Brambilla E., Muller-Hermelink H.K., et al. Pathology and genetics: tumours of the lung, pleura, thymus and heart (2004), IARC, Lyon
3. Travis W.D., Colby T.V., Corrin B., et al. Histological typing of lung and pleural tumours. 3rd edition (1999), Springer-Verlag, Berlin, Germany
4. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
5. Rami-Porta R., Ball D., Crowley J., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2 7 (2007) 593-602
6. Rusch V.W., Crowley J., Giroux D.J., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 7 (2007) 603-612
7. Postmus P.E., Brambilla E., Chansky K., et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2 8 (2007) 686-693
8. Pfister D.G., Johnson D.H., Azzoli C.G., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 2 (2004) 330-353
9. van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 359 9315 (2002) 1388-1393
10. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 25 (2003) 2500-2507
11. Verhagen A.F., Bootsma G.P., Tjan-Heijnen V.C., et al. FDG-PET in staging lung cancer: how does it change the algorithm?. Lung Cancer 44 2 (2004) 175-181
12. Reed C.E., Harpole D.H., Posther K.E., et al. Results of the American college of surgeons oncology group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 126 6 (2003) 1943-1951
13. Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16 (1998) 2142-2149
14. Pieterman R.M., van Putten J.W., Meuzelaar J.J., et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343 4 (2000) 254-261
15. Antoch G., Stattaus J., Nemat A.T., et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229 2 (2003) 526-533
16. Ratto G.B., Piacenza G., Frola C., et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 51 (1991) 182-188
17. Padovani B., Mouroux J., Seksik L., et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 187 1 (1993) 33-38
18. Webb W.R., Gatsonis C., Zerhouni E.A., et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178 (1991) 705-713
19. Martini N., Heelan R., Westcott J., et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg 90 (1985) 639-648
20. McLoud T.C. CT of bronchogenic carcinoma: indeterminate mediastinal invasion. Radiology 173 (1989) 15-16
21. Musset D., Grenier P., Carette M.F., et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 160 (1986) 607-611
22. Glazer H.S., Kaiser L.R., Anderson D.J., et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology 173 (1989) 37-42
23. Herman S.J., Winton T.L., Weisbrod G.L., et al. Mediastinal invasion by bronchogenic carcinoma: CT signs. Radiology 190 (1994) 841-846
24. Webb W.R., and Sostman H.D. MR imaging of thoracic disease: clinical uses. Radiology 182 (1992) 621-630
25. Bruzzi J., Komaki R., Walsh G., et al. Comprehensive review of superior sulcus tumors. Part II: imaging: initial staging, assessment of resectability and therapeutic response. Radiographics (2007) in press
26. Bilsky M.H., Vitaz T.W., Boland P.J., et al. Surgical treatment of superior sulcus tumors with spinal and brachial plexus involvement. J Neurosurg 97 3 Suppl (2002) 301-309
27. Gandhi S., Walsh G.L., Komaki R., et al. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 68 5 (1999) 1778-1784 [discussion: 84-5]
28. York J.E., Walsh G.L., Lang F.F., et al. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 91 Suppl 1 (1999) 74-80
29. Dartevelle P., and Macchiarini P. Surgical management of superior sulcus tumors. Oncologist 4 5 (1999) 398-407
30. Galetta D., Cesario A., Margaritora S., et al. Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach. Ann Thorac Surg 76 6 (2003) 1802-1808 [discussion: 8-9]
31. Ichinose Y., Fukuyama Y., Asoh H., et al. Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer. Ann Thorac Surg 76 6 (2003) 1810-1814 [discussion: 5]
32. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and the European Respiratory Society. Am J Respir Crit Care Med 156 1 (1997) 320-332
33. Mountain C.F., and Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 111 (1997) 1718-1723
34. Glazer G.M., Gross B.H., Quint L.E., et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society Mapping. Am J Roentgenol 144 (1985) 261-265
35. Prenzel K.L., Monig S.P., Sinning J.M., et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123 2 (2003) 463-467
36. De Leyn P., Vansteenkiste J., Cuypers P., et al. Role of cervical mediastinoscopy in staging of non-small cell lung cancer without enlarged mediastinal lymph nodes on CT scan. Eur J Cardiothorac Surg 12 5 (1997) 706-712
37. Choi Y.S., Shim Y.M., Kim J., et al. Mediastinoscopy in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 75 2 (2003) 364-366
38. Toloza E.M., Harpole L., Detterbeck F., et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 123 Suppl 1 (2003) 157S-166S
39. Birim O., Kappetein A.P., Stijnen T., et al. Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg 79 1 (2005) 375-382
40. Gould M.K., Kuschner W.G., Rydzak C.E., et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 139 11 (2003) 879-892
41. de Langen A.J., Raijmakers P., Riphagen I., et al. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 29 1 (2006) 26-29
42. Dietlein M., Weber K., Gandjour A., et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 27 11 (2000) 1598-1609
43. Scott W.J., Shepherd J., and Gambhir S.S. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 66 (1998) 1876-1885
44. MacManus M.P., Hicks R.J., Matthews J.P., et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50 2 (2001) 287-293
45. Viney R.C., Boyer M.J., King M.T., et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 22 12 (2004) 2357-2362
46. Lardinois D., Weder W., Roudas M., et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol 23 28 (2005) 6846-6853
47. Mayo-Smith W.W., Boland G.W., Noto R.B., et al. State-of-the-art adrenal imaging. Radio Graphics 21 4 (2001) 995-1012
48. Boland G.W., Lee M.J., Gazelle G.S., et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am J Roentgenol 171 (1998) 201-204
49. Pena C.S., Boland G.W., Hahn P.F., et al. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217 3 (2000) 798-802
50. Boland G.W., and Lee M.J. Magnetic resonance imaging of the adrenal gland. Crit Rev Diagn Imaging 36 (1995) 115-174
51. Outwater E.K., Siegelman E.S., Huang A.B., et al. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200 3 (1996) 749-752
52. Schwartz L.H., Ginsberg M.S., Burt M.E., et al. MRI as an alternative to CT-guided biopsy of adrenal masses in patients with lung cancer. Ann Thorac Surg 65 1 (1998) 193-197
53. Remer E.M., Obuchowski N., Ellis J.D., et al. Adrenal mass evaluation in patients with lung carcinoma: a cost-effectiveness analysis. Am J Roentgenol 174 4 (2000) 1033-1039
54. Yun M., Kim W., Alnafisi N., et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 42 12 (2001) 1795-1799
55. Erasmus J.J., Patz E.F., McAdams H.P., et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma by using 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 168 (1997) 1357-1360
56. Ferrigno D., and Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small-cell lung cancer. Chest 106 (1994) 1025-1029
57. Hooper R.G., Tenholder M.F., Underwood G.H., et al. Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. Chest 85 (1984) 774-776
58. Mintz B.J., Tuhrim S., Alexander S., et al. Intracranial metastases in the initial staging of bronchogenic carcinoma. Chest 86 (1984) 850-853
59. Newman S.J., and Hansen H.H. Proceedings: frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 33 2 (1974) 492-496
60. Salvatierra A., Baamonde C., Llamas J.M., et al. Extrathoracic staging of bronchogenic carcinoma. Chest 97 (1990) 1052-1058
61. Colice G.L., Birkmeyer J.D., Black W.C., et al. Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest 108 (1995) 1264-1271
62. Silvestri G.A., Littenberg B., and Colice G.L. The clinical evaluation for detecting metastatic lung cancer. A meta-analysis. Am J Respir Crit Care Med 152 1 (1995) 225-230
63. Yokoi K., Kamiya N., Matsuguma H., et al. Detection of brain metastasis in potentially operable non-small cell lung cancer. A comparison of CT and MRI. Chest 115 (1999) 714-719
64. Figlin R.A., Piantadosi S., and Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med 318 20 (1988) 1300-1305
65. Robnett T.J., Machtay M., Stevenson J.P., et al. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol 19 5 (2001) 1344-1349
66. Earnest IV F., Ryu J.H., Miller G.M., et al. Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection-pilot study. Radiology 211 1 (1999) 137-145
67. Little A.G., and Stitik F.P. Clinical staging of patients with non-small cell lung cancer. Chest 97 (1990) 1431-1438
68. Michel F., Soler M., Imhof E., et al. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax 46 (1991) 469-473
69. Bury T., Barreto A., Daenen F., et al. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25 9 (1998) 1244-1247
70. Hsia T.C., Shen Y.Y., Yen R.F., et al. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 49 4 (2002) 267-271
71. Ginsberg R.J. Continuing controversies in staging NSCLC: an analysis of the revised 1997 staging system. Oncology (Huntingt) 12 1 Suppl 2 (1998) 51-54
72. Kameyama K., Huang C.L., Liu D., et al. Problems related to TNM staging: patients with stage III non-small cell lung cancer. J Thorac Cardiovasc Surg 124 3 (2002) 503-510
73. Naruke T., Goya T., Tsuchiya R., et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 (1988) 440-447
74. Carbone E., Asamura H., Takei H., et al. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. J Thorac Cardiovasc Surg 122 5 (2001) 907-912
75. Vallieres E., Karmy-Jones R., Mulligan M.S., et al. Pancoast tumors. Curr Probl Surg 38 5 (2001) 293-376
76. Ginsberg R.J., Martini N., Zaman M., et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 57 6 (1994) 1440-1445
77. Hilaris B.S., Martini N., Wong G.Y., et al. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 67 5 (1987) 965-977
78. Darling G.E. Staging of the patient with small cell lung cancer. Chest Surg Clin N Am 7 (1997) 81-94
79. Stitik F.P. The new staging of lung cancer. Radiol Clin North Am 32 (1994) 635-647
80. Jelinek J.S., Redmond J., Perry J.J., et al. Small cell lung cancer: staging with MR imaging. Radiology 177 (1990) 837-842
81. Kut V., Spies W., Spies S., et al. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). Am J Clin Oncol 30 1 (2007) 45-50
82. Niho S., Fujii H., Murakami K., et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Lung Cancer 57 5 (2007) 328-333
83. Brink I., Schumacher T., Mix M., et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 31 12 (2004) 1614-1620
84. Bradley J.D., Dehdashti F., Mintun M.A., et al. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 22 16 (2004) 3248-3254
85. Abrams J., Doyle L.A., and Aisner J. Staging prognostic factors, and special considerations in small cell lung cancer. Semin Oncol 15 (1988) 261-277
86. Stahel R.A., Mabry M., Skarin A.T., et al. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3 4 (1985) 455-461
87. Stahel R.A., Ginsberg R., Havemann K., et al. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 5 (1989) 119-126
88. Bunn Jr. P.A., and Rosen S.T. Central nervous system manifestations of small cell lung cancer. In: Aisner J. (Ed). Contemporary issues in clinical oncology: lung cancer (1985), Churchill Livingstone, New York 287-305
89. Elias A.D. Small cell lung cancer. State-of-the-art therapy in 1996. Chest 112 (1997) 251S-258S
90. van de Pol M., van Oosterhout A.G.M., Wilmink J.T., et al. MRI in detection of brain metastases at initial staging of small-cell lung cancer. Neuroradiology 38 (1996) 207-210